Soleus Capital Management’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-51,686
| Closed | -$4.04M | – | 110 |
|
|
2023
Q1 | $4.04M | Buy |
51,686
+39,186
| +313% | +$3.06M | 0.42% | 53 |
|
|
2022
Q4 | $1.04M | Sell |
12,500
-39,186
| -76% | -$3.26M | 0.15% | 64 |
|
|
2022
Q3 | $4.76M | Hold |
51,686
| – | – | 0.65% | 44 |
|
|
2022
Q2 | $7.73M | Hold |
51,686
| – | – | 1.21% | 29 |
|
|
2022
Q1 | $12.5M | Buy |
51,686
+43,093
| +501% | +$10.4M | 1.62% | 23 |
|
|
2021
Q4 | $2.6M | Sell |
8,593
-657
| -7% | -$199K | 0.26% | 49 |
|
|
2021
Q3 | $3.83M | Buy |
+9,250
| New | +$3.83M | 0.6% | 41 |
|
|
2021
Q2 | – | Sell |
-6,250
| Closed | -$1.29M | – | 78 |
|
|
2021
Q1 | $1.29M | Hold |
6,250
| – | – | 0.23% | 61 |
|
|
2020
Q4 | $1.25M | Hold |
6,250
| – | – | 0.16% | 48 |
|
|
2020
Q3 | $1.04M | Buy |
+6,250
| New | +$1.04M | 0.55% | 42 |
|